GreenLight Biosciences set to begin trading under Nasdaq: GRNA on February 3, 2022
The company’s press release may be found here from PR Newswire.
The company’s press release may be found here from PR Newswire.
Lewis & Clark Ventures was founded by former operators with the conviction that innovation and entrepreneurial talent are plentiful outside of traditional capital centers. We partner with high potential Late Seed and Series A stage B2B software companies. Our vision for success is to become a trusted partner to every entrepreneur that we back and assist in their journey towards scale and significance.